They demonstrated that LyP-1, a cyclic 9-amino acid peptide, was able to bind to p32 protein, a biomarker in the progression of atherosclerosis, but the binding affinity of LyP-1 was relatively low in aorta (Hamzah et al., 2011). Here, PTPN22 is linked to atherosclerosis.